<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Radiat Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Radiat Oncol</journal-id>
      <journal-title-group>
        <journal-title>Radiation Oncology (London, England)</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1748-717X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23786884</article-id>
      <article-id pub-id-type="pmc">3702489</article-id>
      <article-id pub-id-type="publisher-id">1748-717X-8-147</article-id>
      <article-id pub-id-type="doi">10.1186/1748-717X-8-147</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Ceovic</surname>
            <given-names>Romana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>romana.ceovic@zg.htnet.hr</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Jovanovic</surname>
            <given-names>Ivana</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>ivanajovanovic@net.hr</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Kostovic</surname>
            <given-names>Kresimir</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kreso.kostovic@zg.t-com.hr</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Rados</surname>
            <given-names>Jaka</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sodarakaj@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Dotlic</surname>
            <given-names>Snjezana</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>sdotlic30@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Radman</surname>
            <given-names>Ivo</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>iradman@net.hr</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Kulisic</surname>
            <given-names>Sandra Marinovic</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sandra.marinovic@zg.htnet.hr</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Loncaric</surname>
            <given-names>Davorin</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>davorinloncaric@yahoo.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Dermatology and Venereology, University Hospital Center Zagreb and School of Medicine, Zagreb, Croatia</aff>
      <aff id="I2"><label>2</label>Department of Dermatology and Venereology, Dr. Josip Ben&#x10D;evi&#x107; General Hospital, Slavonski Brod, Croatia</aff>
      <aff id="I3"><label>3</label>Department of Pathology, University Hospital Center Zagreb and School of Medicine, Zagreb, Croatia</aff>
      <aff id="I4"><label>4</label>Department of Hematology, University Hospital Center Zagreb and School of Medicine Zagreb, Zagreb, Croatia</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>6</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <fpage>147</fpage>
      <lpage>147</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>6</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Ceovic et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Ceovic et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.ro-journal.com/content/8/1/147"/>
      <abstract>
        <p>Primary cutaneous follicle center lymphoma is an indolent primary cutaneous B-cell lymphoma originating from the follicle center cells, composed of a combination of centrocytes (small and large cleaved cells) and centroblasts (large noncleaved cells) with a follicular, follicular/diffuse, or diffuse growth pattern. Lesions are mostly located on the head, neck and trunk. A case is presented of a 56-year-old male patient with primary cutaneous follicle center lymphoma, with lesions involving the skin of the back, shoulders, presternal area and right forearm. As the patient presented a disseminated cutaneous form of the disease that involved several anatomical regions, complete work-up was followed by superficial fractionated radiotherapy of eight fields in VI expositions, with total irradiation dose of 1400&#xA0;cGy upon the following fields: right and left pectoral region, left and right shoulders, right suprascapular region, and proximal third of the right forearm. Total irradiation dose applied upon each field for the lesions located on the left and right side of the back was 1500&#xA0;cGy. This therapy resulted in significant reduction of visible tumor. The patient was regularly followed up on outpatient basis for 12&#xA0;months of radiotherapy, being free from local recurrence and systemic spread of the disease.</p>
      </abstract>
      <kwd-group>
        <kwd>Primary Cutaneous Follicle Center Lymphoma</kwd>
        <kwd>Superficial</kwd>
        <kwd>Fractionated Radiotherapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Primary cutaneous follicle center lymphoma (PCFCL) can be defined as neoplastic proliferation of the follicle germinal center cells limited to the skin. PCFCL is a primary cutaneous B-cell lymphoma composed of neoplastic B-cells with morphological and immunophenotypic properties of follicle center cells, usually a combination of centrocytes (small and large cleaved center cells) and a variable number of centroblasts (large noncleaved follicle center cells with prominent nucleoli). According to growth pattern, it is divided into follicular, diffuse and mixed pattern. This type of lymphoma is described as a separate entity in the WHO-EORTC classification of primary cutaneous lymphomas [<xref ref-type="bibr" rid="B1">1</xref>], as well as in the new WHO classification of hematopoietic and lymphoid tissue tumors [<xref ref-type="bibr" rid="B2">2</xref>]. The diagnosis of PCFCL is made in 11% of all patients with cutaneous lymphomas [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>All cutaneous lymphomas require complete work-up including staging in order to rule out extracutaneous lymphoma of similar morphology [<xref ref-type="bibr" rid="B3">3</xref>]. Disease staging includes physical examination, laboratory testing, chest x-ray, ultrasonography (US) of lymph nodes and visceral organs, computed tomography (CT) of the chest, abdomen and pelvis, and bone marrow biopsy. Besides complete disease history, making an accurate diagnosis requires histopathology, immunophenotyping and molecular studies.</p>
      <p>When extracutaneous disease has been excluded by complete work-up, the diagnosis of primary cutaneous lymphoma can be made [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Fluorodeoxyglucose-positron emission tomography (FDG-PET), recently increasingly employed, can be performed as an additional study, along with bone marrow biopsy [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. As comparison of FDG-PET and bone marrow biopsy findings showed no major differences in their accuracy and specificity, the authors concluded that FDG-PET could be used as an additional study to bone marrow biopsy, in the work-up of malignant lymphoma in particular [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>The etiology of PCFCL remains unknown, however, association with <italic>Borrelia burgdorferi</italic>, hepatitis C or human herpesvirus 8 infection has been occasionally described [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. In the majority of cases, adults of both sexes are affected, whereas PCFCL is rare in childhood [<xref ref-type="bibr" rid="B12">12</xref>]. Clinical picture is characterized by the occurrence of solitary or grouped erythematous papules, plaques and tumor lesions, mostly non-ulcerated. The lesions are usually localized in the head, neck and trunk areas, less frequently on lower extremities [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. The lesions localized on the back were in the past known as Crosti lymphoma or reticulohistiocytoma of the back [<xref ref-type="bibr" rid="B14">14</xref>]. There is no strict differentiation in clinical picture and localization of follicular and diffuse PCFCL; however, the former are predominantly found in the head and neck region, and the latter on the trunk [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Generally, PCFCL is a localized disease rarely associated with extracutaneous dissemination [<xref ref-type="bibr" rid="B18">18</xref>].</p>
      <p>The histopathologic picture of PCFCL varies depending on the duration, stage of lesion growth as revealed by biopsy specimen, and localization [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Most slides show nodular to diffuse infiltrates with normal epidermis. Minor and initial lesions contain a mixed picture of centrocytes, some centroblasts, and less reactive T cells. Large centrocytes are characteristic of PCFCL. Large neoplastic B-cells may resemble fibroblasts. Follicular growth can be clearly observed in minor and/or initial lesions. Well differentiated diffuse PCFCL lesions involve the entire dermis, frequently spreading to the subcutaneous adipose tissue. The lesions are characterized by proliferation of small, medium-sized and large cleaved cells (centrocytes) admixed with a variable number of large cells with morphological characteristics of centroblasts. Small reactive T lymphocytes are mostly intertwined with tumor cells. Histologic slide with biopsy specimen of a lesion with follicular growth pattern may mimick follicular extracutaneous lymphoma [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. PCFCL with follicular growth is composed of nodular infiltrates in the dermis, usually with subcutaneous tissue involvement, characterizing the follicular growth basis. If present, neoplastic follicles show morphological abnormalities such as reduced or absent mantle cell zone, reduced or completely absent stained body macrophages, and monomorphous phenomenon without clearly delineated dark and light areals. Cytomorphologically, neoplastic follicles consist of small and large centrocytes linked to centroblasts, frequently mixed with small reactive lymphocytes. In some cases, both diffuse and follicular growth characteristics are found in the same tumor; residual follicles are seen on the infiltrate periphery, while diffuse growth predominates in the central part. The morphological variants of PCFCL showing nodules of medium-sized centrocytes mixed with centroblasts without prominent interfollicular infiltrate were earlier known as large-cell lymphocytoma [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. As the tumor lesion grows, neoplastic B lymphocytes also grow and replicate, while the number of reactive T cells is on a decrease [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. The stromal component is usually very pronounced.</p>
      <p>In case of either diffuse or neoplastic PCFCL, neoplastic cells are positive for CD20 and CD79a B-cell markers. In most cases of PCFCL with diffuse growth characteristics, cells are CD10- and without a network of CD21 follicular dendritic cells in the background. In contrast, in PCFCL with follicular growth cells are positive for CD10 and Bcl-6 markers [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. The presence of small CD10+ and/or Bcl-6+ clusters outside the neoplastic follicles may be occasionally seen [<xref ref-type="bibr" rid="B17">17</xref>]. This phenomenon caused by &#x2018;active migration&#x2019; of neoplastic follicular cells from the follicles toward the interfollicular space and back, has been described in nodal follicular lymphomas [<xref ref-type="bibr" rid="B26">26</xref>]. Other markers can be used to verify differentiation of the neoplastic cell germinal center, such as paired box gene (PAX)-5 gene and interferon regulatory factor (IRF) 8, however, other B-cells are also positive for these markers [<xref ref-type="bibr" rid="B27">27</xref>]. On the slides with visible diffuse and follicular growth features, CD21+ follicular dendritic cells are located in the periphery of larger areals with a diffuse growth pattern. Residual network of CD21 follicular dendritic cells is mostly found within neoplastic follicles. Unlike nodal follicular lymphoma, expression of bcl-2 is generally rare [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Bcl-2 positive cells are infrequently found in PCFCL, localized within the follicular center in 10%-15% of cases and only rarely in the entire neoplastic population [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. Multiple myeloma oncogene-1 (MUM-1) is positive in less than 30% of PCFCL cells [<xref ref-type="bibr" rid="B36">36</xref>]. Polyclonal plasma cells with no restriction of &#x3BA; and &#x3BB; chains are frequent in patients with cutaneous lymphoma [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B37">37</xref>].</p>
      <p>In most cases, PCFCL shows monoclonal distribution of the J<sub>H</sub> gene, but also a reduced detection of this distribution by the PCR method. This might be, at least in part, due to the high number of somatic hypermutations characteristic of this tumor. Somatic hypermutations of variable heavy and light chains can be observed, confirming this lymphoma to originate from the follicular center cells [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. Numerous literature data clearly demonstrate that PCFCL generally is not associated with t(14;18) translocation [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B40">40</xref>-<xref ref-type="bibr" rid="B44">44</xref>]. The presence of t(14;18) translocation is characteristic of systemic follicular lymphomas and part of systemic diffuse large cell B-lymphomas [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B40">40</xref>].</p>
      <p>Inactivity of the p15 and p16 tumor suppressor genes may be detected in 10%-30% of cases [<xref ref-type="bibr" rid="B45">45</xref>]. In most patients with solitary or multiple lesions generally localized on the head and trunk, therapy of choice is radiotherapy based on histologic classification according to the growth pattern and number of blast cells, and the prognosis is good in these patients [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B51">51</xref>]. Radiotherapy is first-line therapy also for tumor lesions with histologically predominant large cleaved cells [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B52">52</xref>-<xref ref-type="bibr" rid="B55">55</xref>]. Skin relapses, seen in 20% of patients, which do not readily suggest disease progression, can also be treated with radiotherapy [<xref ref-type="bibr" rid="B56">56</xref>]. In case of localized skin lesions, excision of tumor lesions should be considered, followed by radiotherapy of the operative field and adjacent skin [<xref ref-type="bibr" rid="B15">15</xref>]. Chemotherapy is indicated for extensive and spread skin lesions and in patients developing extracutaneous disease [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. Systemic and intralesional interferon &#x3B1;, or in combination with other therapeutic procedures, can also be taken in consideration [<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B61">61</xref>].</p>
      <p>Recent studies report on therapeutic results recorded with systemic or intralesional anti-CD20 antibody therapy in PCFCL patients [<xref ref-type="bibr" rid="B62">62</xref>-<xref ref-type="bibr" rid="B68">68</xref>]. Rituximab (anti-CD20 antibody) can be therapeutically combined with systemic chemotherapy in patients with generalized skin disease, extracutaneous disease, or relapsing cutaneous lesions [<xref ref-type="bibr" rid="B69">69</xref>]. Taking the growth pattern, blast cell count, and presence of solitary or multiple cutaneous lesions into consideration, PCFCL has a good prognosis with 5-year survival of about 95% [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. There is no substantial prognosis difference between tumor lesions with a follicular growth pattern and tumor lesions with diffuse growth pattern [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>], but some studies indicate that poorer prognosis should be expected in PCFCL cases with diffuse growth pattern, pronounced bcl-2 expression and histologically visible large cells [<xref ref-type="bibr" rid="B70">70</xref>].</p>
      <p>In spite of the possible occurrence of local relapses, seen in some 20% of cases, extracutaneous dissemination of the disease is uncommon. There are only rare cases of disease dissemination to the central nervous system [<xref ref-type="bibr" rid="B70">70</xref>].</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 56-year-old male patient presented to our Department for cutaneous lesions that had first appeared four years before. Clinical picture included numerous erythematous and erythematous-livid infiltrates, 2&#x2013;8&#xA0;cm in diameter, on his upper back, shoulders, in the presternal region and in the proximal third of his right forearm [Figures&#xA0;<xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>]. There was no enlargement of the palpable lymph nodes and the patient denied any subjective discomforts of pain or itch. He had been treated for type 2 diabetes mellitus and arterial hypertension for years and regulary checked for multipli naevi pigmentosi on the trunk.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>A 56-year old male patient with numerous erythematous and livid infiltrates before superficial radiotherapy.</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>A 56-year old male patient with numerous erythematous and livid infiltrates before superficial radiotherapy.</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-2"/>
      </fig>
      <p>Laboratory findings: complete blood count, urine, blood glucose, liver enzymes, bilirubin, urea, creatinine, lipid profile, creatine kinase, lactate dehydrogenase, C-reactive protein, protein electrophoresis, immunoglobulins, and serum Cu were within the reference values. Serology for hepatitis C and B viruses and <italic>Borrelia burgdorferi </italic>[<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>], and HIV-ELISA produced negative findings.</p>
      <p>Biopsy specimens were obtained from lesions on the left shoulder, the back and the right shoulder. Histopathology of all three specimens revealed superficially regular, preserved epidermis and diffuse full-depth lymphocyte infiltration of the excised dermis [Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>]. In the deep dermis, there was abundant lymphocytic infiltrate with the formation of follicular germinal center and the surrounding &#x2018;mantle zone&#x2019;. The infiltrate was composed of atypical, medium-sized and focally large lymphatic cells [Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>].</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>The epidermis is preserved, with diffuse and nodular infiltrates of lymphoid cells.</bold> (H&amp;E, magnification 40&#xD7;).</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>The infiltrate is composed of atypical, medium-sized and focally large lymphatic cells.</bold> (H&amp;E, magnification 400&#xD7;).</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-4"/>
      </fig>
      <p>Immunohistochemistry showed the atypical, medium-sized and focally large lymphatic cells to be CD20+, bcl-6+, bcl-2 weakly positive, CD10-, MUM1-, CD3- and CD5- [Figure&#xA0;<xref ref-type="fig" rid="F5">5</xref>A,B]. Staining for &#x3BA; and &#x3BB; chains demonstrated rare polyclonal plasma cells peripherally. Staining for CD21 showed the follicular dendritic network to be preserved and focally extended.</p>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Immunohistochemical staining for CD20 demonstrates diffusely positive reaction in tumour cells (A: IHC, CD20, magnification 20&#xD7;), coexpressing BCL6 (B: IHC, BCL6, magnification 400&#xD7;).</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-5"/>
      </fig>
      <p>Clonal B lymphocyte population was demonstrated by molecular analysis using the PCR method with analysis of rearrangement in the gene for immunoglobulin heavy chain and the gene for immunoglobulin light chain of kappa type (IgK).</p>
      <p>Considering the histologic picture and verified clonality, the finding corresponded to the skin infiltration with B-immunophenotype lymphoma, requiring further exclusion of extracutaneous lymphoma [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>The patient was referred to a hematologist; based on hematologic examination and the findings available, the hematologist suggested ruling out systemic disease and recommended bone marrow biopsy and multi-slice computed tomography (MSCT).</p>
      <p>Bone marrow biopsy revealed no evidence of tumor.</p>
      <p>MSCT of the thorax, abdomen and pelvis showed no lymphadenopathy, however, visualizing multiple concrements up to 8&#xA0;mm in size in the cholecyst.</p>
      <p>Upon complete work-up, and considering the histologic picture, verified clonality and exclusion of extracutaneous spread of the disease, the finding was consistent with the picture of PCFCL.</p>
      <p>As our patient had a disseminated cutaneous form of the disease involving multiple anatomic regions, we decided on the use of superficial fractionated radiotherapy [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B51">51</xref>], administered upon eight fields in VI expositions, with total irradiation dose of 1400&#xA0;cGy, on the following irradiation fields: left and right pectoral region, left and right shoulder, right suprascapular region, and proximal third of the right forearm. Total dose received <italic>per</italic> field upon lesions on the left and right side of the back was 1500&#xA0;cGy. This therapy resulted in significant reduction of visible tumor [Figures&#xA0;<xref ref-type="fig" rid="F6">6</xref> and <xref ref-type="fig" rid="F7">7</xref>. Post-radiotherapy skin appearance]. The patient was regularly followed up for <italic>12</italic>&#x2009;months following radiotherapy and remained free from local relapse or extracutaneous dissemination of the disease. Staging of the disease can be repeated in case of relapse or every 12&#xA0;months (heart and lung x-ray is usually repeated every 2&#x2013;3&#xA0;years).</p>
      <fig id="F6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Post-radiotherapy appearance.</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-6"/>
      </fig>
      <fig id="F7" position="float">
        <label>Figure 7</label>
        <caption>
          <p>Post-radiotherapy appearance.</p>
        </caption>
        <graphic xlink:href="1748-717X-8-147-7"/>
      </fig>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In the patient presented, the diagnosis of PCFCL with follicular growth pattern was made by complete work-up and exclusion of systemic disease. Although it is an indolent B-cell lymphoma, appropriate approach to the patient and complete diagnostic work-up are necessary as in all cutaneous lymphomas. Close collaboration of specialists in dermatology, pathology, cytology and hematology is of utmost importance to reach an accurate diagnosis, to perform proper disease staging, and to choose the most suitable therapeutic modality.</p>
      <p>Of the known therapeutic procedures, we decided to use superficial fractionated radiotherapy upon eight fields, which led to the significant reduction of visible tumor.</p>
      <p>Patients with this type of cutaneous lymphoma have good prognosis, with the expected 5-year survival of 95% and rare systemic disease development. Skin relapses are reported in 20% of cases and are treated with radiotherapy. Our patient has been on regular follow up for possible skin relapses or extracutaneous disease dissemination.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>RC, IJ and KK are doctors who were treating patient from the first day he came to the Clinic. They have made substantial contributions to his treatment, acquisition of data, analysis and interpretation of data. They have been involved in drafting the manuscript or revising it critically for important intellectual content; and have given final approval of the version to be published. JR,SD and DL are dermatopathologists who made histopathology and immunohistochemistry, SMK was patient&#x2019;s leading doctor during hospitalization, IR is hematologist who have made substantial contributions to conception of diagnostic procedures, analysis of data and treatmant. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; information</title>
      <p>Assist. Professor Romana Ceovic is Head of the Department of Dermatological Oncology at the University Hospital, Zagreb, Croatia and Head of Refferal Center for Dermatooncology in Croatia. Her current interests include radiotherapy of skin tumors.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jaffe</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Burg</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Swerdlow</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Ralfkiaer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chimenti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diaz-Perez</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Duncan</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Grange</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Kempf</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kurrer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Knobler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Santucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sterry</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Wechsler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Whittaker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <article-title>WHO-EORTC classification of cutaneous lymphomas</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>105</volume>
          <fpage>3768</fpage>
          <lpage>3785</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2004-09-3502</pub-id>
          <pub-id pub-id-type="pmid">15692063</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="book">
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Swerdlow</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Vrgier</surname>
            <given-names>B</given-names>
          </name>
          <person-group person-group-type="editor">Swerdlow SH</person-group>
          <article-title>Primary cutaneous follicle center lymphoma</article-title>
          <source>Classification of Tumours of Haematopoietic and Lymphoid Tissues</source>
          <year>2008</year>
          <edition>2</edition>
          <publisher-name>Lyon: IARC Press</publisher-name>
          <fpage>227</fpage>
          <lpage>228</lpage>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Senff</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Kluin- Nelemans</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma</article-title>
          <source>Br J Haematol</source>
          <year>2008</year>
          <volume>142</volume>
          <fpage>52</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2141.2008.07159.x</pub-id>
          <pub-id pub-id-type="pmid">18422781</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fink-Puches</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zenahlik</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Back</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Smolle</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Primary cutaneous lymphomas: applicability of current classification schemes (European Organisation for Research and Treatment of Cancer, World Health Organisation) based on clinicopathologic features observed in a large group of patients</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>800</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="doi">10.1182/blood.V99.3.800</pub-id>
          <pub-id pub-id-type="pmid">11806979</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pelosi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Penna</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Deandreis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Chiappella</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Skanjeti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vitolo</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Bisi</surname>
            <given-names>G</given-names>
          </name>
          <article-title>FDG-PET in the detection of bone marrow disease in Hodgkin&#x2019;s disease and aggressive non-Hodgkin&#x2019;s lymphoma and its impact on clinical management</article-title>
          <source>Q J Nucl Med Mol Imaging</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>9</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">18235420</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kuo</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>McClennan</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Edelson</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Heald</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Girardi</surname>
            <given-names>M</given-names>
          </name>
          <article-title>FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma</article-title>
          <source>Mol Imaging Biol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>74</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1007/s11307-007-0127-y</pub-id>
          <pub-id pub-id-type="pmid">18196347</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pelosi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Penna</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Douroukas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bell&#xF2;</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Amati</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Arena</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Passera</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bisi</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study</article-title>
          <source>Q J Nucl Med Mol Imaging</source>
          <year>2011</year>
          <volume>55</volume>
          <fpage>469</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">21150862</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Z&#xF6;chling</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>P&#xFC;tz</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Infection by <italic>Borrelia burgdorferi</italic> and cutaneous B-cell lymphoma</article-title>
          <source>J Cutan Pathol</source>
          <year>1997</year>
          <volume>24</volume>
          <fpage>457</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.1997.tb01318.x</pub-id>
          <pub-id pub-id-type="pmid">9331890</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goodlad</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Davidson</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Hollowood</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ling</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>MacKenzie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Christie</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Batstone</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ho-Yen</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Primary cutaneous B-cell lymphoma and <italic>Borrelia burgdorferi</italic> infection in patients from the highlands of Scotland</article-title>
          <source>Am J Surg Pathol</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>1279</fpage>
          <lpage>1285</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200009000-00012</pub-id>
          <pub-id pub-id-type="pmid">10976703</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Z&#xF6;chling</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>P&#xFC;tz</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Human herpesvirus 8-specific DNA sequences in primary cutaneous B-cell lymphomas</article-title>
          <source>Arch Dermatol</source>
          <year>1998</year>
          <volume>134</volume>
          <fpage>246</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="doi">10.1001/archderm.134.2.246</pub-id>
          <pub-id pub-id-type="pmid">9487226</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Viguier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rivet</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Agbalika</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kerviler</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Brice</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Dubertret</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bachelez</surname>
            <given-names>H</given-names>
          </name>
          <article-title>B-cell lymphomas involving the skin associated with hepatitis C virus infection</article-title>
          <source>Int J Dermatol</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>577</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-4362.2002.01603.x</pub-id>
          <pub-id pub-id-type="pmid">12358827</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ghislanzoni</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gambini</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Perrone</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Alessi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Primary cutaneous follicular center cell lymphoma of the nose with maxillary sinus involvement in a pediatric patient</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>s73</fpage>
          <lpage>s75</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2004.05.025</pub-id>
          <pub-id pub-id-type="pmid">15858514</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Sentis</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Scheffer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>van Vloten</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Toonstra</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van der Putte</surname>
            <given-names>SC</given-names>
          </name>
          <article-title>Primary cutaneous large cell lymphomas of follicular center origin</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1987</year>
          <volume>16</volume>
          <fpage>518</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(87)70068-1</pub-id>
          <pub-id pub-id-type="pmid">3546419</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Alessi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Caputo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gianotti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Delia</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vezzoni</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Reticulohistiocytoma of the dorsum</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1988</year>
          <volume>19</volume>
          <fpage>259</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(88)70169-3</pub-id>
          <pub-id pub-id-type="pmid">3049688</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Arganini</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Primary cutaneous B-cell lymphoma: a unique type of low grade lymphoma</article-title>
          <source>Cancer</source>
          <year>1991</year>
          <volume>67</volume>
          <fpage>2311</fpage>
          <lpage>2326</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19910501)67:9&lt;2311::AID-CNCR2820670918&gt;3.0.CO;2-0</pub-id>
          <pub-id pub-id-type="pmid">2013039</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Santucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Carli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Paglierani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bosi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moretti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Giannotti</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Primary cutaneous follicular center cell lymphoma: clinical and histological aspects</article-title>
          <source>Curr Probl Dermatol</source>
          <year>1990</year>
          <volume>19</volume>
          <fpage>203</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">2404678</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Arzberger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>P&#xFC;tz</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>H&#xF6;fler</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Metze</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Rose</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>R&#xFC;tten</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>McNiff</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Primary cutaneous follicle center cell lymphoma with follicular growth pattern</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>95</volume>
          <fpage>3922</fpage>
          <lpage>3928</lpage>
          <pub-id pub-id-type="pmid">10845929</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Groves</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Linet</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Travis</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Devesa</surname>
            <given-names>SS</given-names>
          </name>
          <article-title>Cancer surveillance series: non-Hodgkin&#x2019;s lymphoma incidence by histologic subtype in the United States from 1978 through 1995</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2000</year>
          <volume>92</volume>
          <fpage>1240</fpage>
          <lpage>1251</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/92.15.1240</pub-id>
          <pub-id pub-id-type="pmid">10922409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Scheffer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kluin</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Van Vloten</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Toonstra</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Van der Putte</surname>
            <given-names>SC</given-names>
          </name>
          <article-title>Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients</article-title>
          <source>Am J Pathol</source>
          <year>1987</year>
          <volume>126</volume>
          <fpage>325</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">3548403</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nathwani</surname>
            <given-names>BN</given-names>
          </name>
          <name>
            <surname>Winberg</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Diamond</surname>
            <given-names>LW</given-names>
          </name>
          <name>
            <surname>Bearman</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Morphologic criteria for the differentiation of follicular lymphoma from florid reactive follicular hyperplasia: a study of 80 cases</article-title>
          <source>Cancer</source>
          <year>1981</year>
          <volume>48</volume>
          <fpage>1794</fpage>
          <lpage>1806</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19811015)48:8&lt;1794::AID-CNCR2820480817&gt;3.0.CO;2-M</pub-id>
          <pub-id pub-id-type="pmid">7026023</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Englisch</surname>
            <given-names>JSC</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Spaull</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wilson Jones</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Winkelmann</surname>
            <given-names>RK</given-names>
          </name>
          <article-title>Large cell lymphocytoma: a clinicopathological study</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>181</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2230.1989.tb00927.x</pub-id>
          <pub-id pub-id-type="pmid">2591076</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Winkelmann</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Dabski</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Large cell lymphocytoma: follow up, immunopathology studies, and comparison to cutaneous follicular and Crosti lymphoma</article-title>
          <source>Arch Dermatol Res</source>
          <year>1987</year>
          <volume>279</volume>
          <fpage>s81</fpage>
          <lpage>s87</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00585927</pub-id>
          <pub-id pub-id-type="pmid">3310923</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Leinweber</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Colli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chott</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern</article-title>
          <source>Am J Dermatopathol</source>
          <year>2004</year>
          <volume>26</volume>
          <fpage>4</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1097/00000372-200402000-00002</pub-id>
          <pub-id pub-id-type="pmid">14726817</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoefnagel</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Jansen</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Fleuren</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance</article-title>
          <source>Br J Dermatol</source>
          <year>2003</year>
          <volume>149</volume>
          <fpage>1183</fpage>
          <lpage>1191</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2003.05649.x</pub-id>
          <pub-id pub-id-type="pmid">14674895</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Surti</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Pandya</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Swerdlow</surname>
            <given-names>SH</given-names>
          </name>
          <article-title>Primary and secondary cutaneous diffuse large B-cell lymphoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2003</year>
          <volume>27</volume>
          <fpage>356</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200303000-00009</pub-id>
          <pub-id pub-id-type="pmid">12604892</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dogan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>MQ</given-names>
          </name>
          <name>
            <surname>Aiello</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Diss</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>LX</given-names>
          </name>
          <name>
            <surname>Isaacson</surname>
            <given-names>PG</given-names>
          </name>
          <article-title>Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>91</volume>
          <fpage>4708</fpage>
          <lpage>4714</lpage>
          <pub-id pub-id-type="pmid">9616169</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Volkenandt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rieger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Soyer</surname>
            <given-names>HP</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas</article-title>
          <source>J Invest Dermatol</source>
          <year>1994</year>
          <volume>102</volume>
          <fpage>231</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="doi">10.1111/1523-1747.ep12371768</pub-id>
          <pub-id pub-id-type="pmid">8106752</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Geelen</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Van der Putte</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Kerkhof</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kluin</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>Bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related</article-title>
          <source>Clin Oncol</source>
          <year>1998</year>
          <volume>16</volume>
          <fpage>2080</fpage>
          <lpage>2085</lpage>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goodlad</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Krajewski</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Batstone</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>McKay</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Benton</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Kavanagh</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Lucraft</surname>
            <given-names>HH</given-names>
          </name>
          <collab>Scotland and Newcastle Lymphoma Group</collab>
          <article-title>Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>733</fpage>
          <lpage>741</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200206000-00006</pub-id>
          <pub-id pub-id-type="pmid">12023577</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mirza</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Macpherson</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Paproski</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gascoyne</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Finn</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Hsi</surname>
            <given-names>ED</given-names>
          </name>
          <article-title>Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features</article-title>
          <source>J Clin Oncol</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>647</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.20.3.647</pub-id>
          <pub-id pub-id-type="pmid">11821444</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lawnicki</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Weisenburger</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Aoun</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Wickert</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Greiner</surname>
            <given-names>TC</given-names>
          </name>
          <article-title>The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade</article-title>
          <source>Am J Clin Pathol</source>
          <year>2002</year>
          <volume>118</volume>
          <fpage>765</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="doi">10.1309/2TJU-DNLQ-5JBA-AB4T</pub-id>
          <pub-id pub-id-type="pmid">12428798</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bachmeyer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Khosrotehrani</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Moguelet</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Aractingi</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Primary cutaneous follicular B-cell lymphoma arising at the site of radiotherapy for breast cancer</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>156</volume>
          <fpage>198</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2006.07600.x</pub-id>
          <pub-id pub-id-type="pmid">17199604</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Leval</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>NL</given-names>
          </name>
          <name>
            <surname>Longtine</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ferry</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Duncan</surname>
            <given-names>LM</given-names>
          </name>
          <article-title>Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>732</fpage>
          <lpage>741</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200106000-00004</pub-id>
          <pub-id pub-id-type="pmid">11395550</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rijlaarsdam</surname>
            <given-names>JU</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients</article-title>
          <source>Cancer</source>
          <year>1990</year>
          <volume>65</volume>
          <fpage>2301</fpage>
          <lpage>2306</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19900515)65:10&lt;2301::AID-CNCR2820651023&gt;3.0.CO;2-M</pub-id>
          <pub-id pub-id-type="pmid">2346914</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Triscott</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Ritter</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Swanson</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Wick</surname>
            <given-names>MR</given-names>
          </name>
          <article-title>Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias</article-title>
          <source>J Cutan Pathol</source>
          <year>1995</year>
          <volume>22</volume>
          <fpage>2</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.1995.tb00732.x</pub-id>
          <pub-id pub-id-type="pmid">7751474</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kodama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Massone</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chott</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Metze</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>106</volume>
          <fpage>2491</fpage>
          <lpage>2497</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2005-03-1175</pub-id>
          <pub-id pub-id-type="pmid">15947086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Garcia</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Warnke</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>GS</given-names>
          </name>
          <article-title>Cutaneous follicular lymphoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>1986</year>
          <volume>10</volume>
          <fpage>454</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198607000-00002</pub-id>
          <pub-id pub-id-type="pmid">3524282</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aarts</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bende</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Pals</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>van Noesel</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Aarts</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bende</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Pals</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>van Noesel</surname>
            <given-names>CJ</given-names>
          </name>
          <article-title>VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>3857</fpage>
          <lpage>3864</lpage>
          <pub-id pub-id-type="pmid">9808579</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gellrich</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rutz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Golembowski</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jacobs</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>von Zimmermann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lorenz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Audring</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Muche</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sterry</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jahn</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells: a single cell polymerase chain reaction analysis</article-title>
          <source>J Invest Dermatol</source>
          <year>2001</year>
          <volume>117</volume>
          <fpage>1512</fpage>
          <lpage>1520</lpage>
          <pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01543.x</pub-id>
          <pub-id pub-id-type="pmid">11886516</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Franco</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Fernandez-Vazquez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rodriguez-Peralto</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Bellas</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>L&#xF3;pez-R&#xED;os</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>S&#xE1;ez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Villuendas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Navarrete</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Zarco</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Piris</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Cutaneous follicular B-cell lymphoma: description of a series of 18 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>875</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200107000-00005</pub-id>
          <pub-id pub-id-type="pmid">11420458</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Child</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Russell-Jones</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Woolford</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Calonje</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Photiou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Orchard</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Whittaker</surname>
            <given-names>SJ</given-names>
          </name>
          <article-title>Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma</article-title>
          <source>Br J Dermatol</source>
          <year>2001</year>
          <volume>144</volume>
          <fpage>735</fpage>
          <lpage>744</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2133.2001.04128.x</pub-id>
          <pub-id pub-id-type="pmid">11298531</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Streubel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Scheucher</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Valencak</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huber</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Petzelbauer</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Trautinger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Weihsengruber</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mannhalter</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chott</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas</article-title>
          <source>Am J Surg Pathol</source>
          <year>2006</year>
          <volume>30</volume>
          <fpage>529</fpage>
          <lpage>536</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200604000-00015</pub-id>
          <pub-id pub-id-type="pmid">16625101</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Surti</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Pandya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rabkin</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Swerdlow</surname>
            <given-names>SH</given-names>
          </name>
          <article-title>Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas</article-title>
          <source>Am J Surg Pathol</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>69</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pas.0000146015.22624.c7</pub-id>
          <pub-id pub-id-type="pmid">15613857</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Delia</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Borrello</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pierotti</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Biassoni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gianotti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Alessi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rizzetti</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Caputo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Della Porta</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas</article-title>
          <source>Cancer Res</source>
          <year>1989</year>
          <volume>49</volume>
          <fpage>4901</fpage>
          <lpage>4905</lpage>
          <pub-id pub-id-type="pmid">2503246</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Child</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Scarisbrick</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Calonje</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Orchard</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Russell-Jones</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Whittaker</surname>
            <given-names>SJ</given-names>
          </name>
          <article-title>Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma</article-title>
          <source>J Invest Dermatol</source>
          <year>2002</year>
          <volume>118</volume>
          <fpage>941</fpage>
          <lpage>948</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.01785.x</pub-id>
          <pub-id pub-id-type="pmid">12060387</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sterry</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chimenti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diaz-Per&#xE9;z</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Geerts</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Goos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Knobler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ralfkiaer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Santucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wechsler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van Vloten</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <article-title>EORTC classification of primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organisation for Research and Treatment of Cancer</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>90</volume>
          <fpage>354</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">9207472</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Grange</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hedelin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Beylot-Barry</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D&#x2019;Incan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Delaunay</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vaillant</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Avril</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Bosq</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wechsler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dalac</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Grosieux</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Franck</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Esteve</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bodemer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vergier</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Laroche</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bagot</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the S&#xE9;zary syndrome</article-title>
          <source>The French Study Group on Cutaneous Lymphomas. Blood</source>
          <year>1999</year>
          <volume>93</volume>
          <fpage>3637</fpage>
          <lpage>3642</lpage>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rijlaarsdam</surname>
            <given-names>JU</given-names>
          </name>
          <name>
            <surname>Toonstra</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>OW</given-names>
          </name>
          <name>
            <surname>Noordijk</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy</article-title>
          <source>J Clin Oncol</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>549</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="pmid">8636770</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Santucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bosi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moretti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vallecchi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Messori</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Giannotti</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Primary cutaneous follicular centre-cell lymphoma: a lymphoproliferative disease with favourable prognosis</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>12</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2230.1989.tb00875.x</pub-id>
          <pub-id pub-id-type="pmid">2680175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Piccinno</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Caccialanza</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma</article-title>
          <source>Eur J Dermatol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>49</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">12609782</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Senff</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Noordijk</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Bagot</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dummer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Duvic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hoppe</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rosen</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Whittaker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <collab>European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma</collab>
          <article-title>European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas</article-title>
          <source>Blood</source>
          <year>2008</year>
          <volume>112</volume>
          <fpage>1600</fpage>
          <lpage>1609</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2008-04-152850</pub-id>
          <pub-id pub-id-type="pmid">18567836</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Grange</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bekkenk</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Wechsler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bernengo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bosq</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hedelin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fink Puches</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>van Vloten</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bagot</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study</article-title>
          <source>J Clin Oncol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>3602</fpage>
          <lpage>3610</lpage>
          <pub-id pub-id-type="pmid">11504742</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bekkenk</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Geerts</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Noordijk</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Heule</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>van Voorst Vader</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>van Vloten</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>2471</fpage>
          <lpage>2478</lpage>
          <pub-id pub-id-type="pmid">10561311</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pimpinelli</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Vallecchi</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Local orthvolt radiotherapy in primary cutaneous B- cell lymphomas; results in series of 115 patients</article-title>
          <source>Skin Cancer</source>
          <year>1999</year>
          <volume>14</volume>
          <fpage>219</fpage>
          <lpage>224</lpage>
        </mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Smith</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Glusac</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>McNiff</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Heald</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>LD</given-names>
          </name>
          <article-title>Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>634</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2004.08.044</pub-id>
          <pub-id pub-id-type="pmid">14966086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Senff</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Hoefnagel</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Neelis</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Vermeer</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Noordijk</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <collab>Dutch Cutaneous Lymphoma Group</collab>
          <article-title>Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification</article-title>
          <source>Arch Dermatol</source>
          <year>2007</year>
          <volume>143</volume>
          <fpage>1520</fpage>
          <lpage>1526</lpage>
          <pub-id pub-id-type="doi">10.1001/archderm.143.12.1520</pub-id>
          <pub-id pub-id-type="pmid">18087001</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Parodi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Micalizzi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rebora</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Intralesional natural interferon &#x3B1; in the treatment of Crosti&#x2019; s lymphoma (primary cutaneous B follicular centre-cell lymphoma): report of four cases</article-title>
          <source>J Dermatol Treatm</source>
          <year>1996</year>
          <volume>7</volume>
          <fpage>105</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="doi">10.3109/09546639609089540</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="book">
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Peris</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Torlone</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chimenti</surname>
            <given-names>S</given-names>
          </name>
          <person-group person-group-type="editor">Lambert WC, Giannotti B, van Vloten WA</person-group>
          <article-title>Use of recombinant interferon &#x3B1;-2a in the treatment of cutaneous lymphomas of T- and B-cell lineage</article-title>
          <source>Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin</source>
          <year>1994</year>
          <edition>265</edition>
          <publisher-name>New York: Plenum Press</publisher-name>
          <fpage>545</fpage>
          <lpage>551</lpage>
        </mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Trent</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Romanelli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kerdel</surname>
            <given-names>FA</given-names>
          </name>
          <article-title>Topical targetin and intralesional interferon-&#x3B1; for cutaneous lymphoma of the scalp</article-title>
          <source>Arch Dermatol</source>
          <year>2002</year>
          <volume>138</volume>
          <fpage>1421</fpage>
          <lpage>1423</lpage>
          <pub-id pub-id-type="doi">10.1001/archderm.138.11.1421</pub-id>
          <pub-id pub-id-type="pmid">12437444</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sangfelt</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Erickson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Castro</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Heiden</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Einhorn</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Grand&#xE9;r</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines</article-title>
          <source>Cell Growth Differ</source>
          <year>1997</year>
          <volume>8</volume>
          <fpage>343</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">9056677</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sangfelt</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Erickson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Grander</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Mechanisms of interferon-induced cell cycle arrest</article-title>
          <source>Front Biosci</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>479</fpage>
          <lpage>487</lpage>
          <pub-id pub-id-type="doi">10.2741/Sangfelt</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Heinzerling</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Urbanek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Funk</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Peker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bleck</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Neuber</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Burg</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>von Den Driesch</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Dummer</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma</article-title>
          <source>Cancer</source>
          <year>2000</year>
          <volume>89</volume>
          <fpage>1835</fpage>
          <lpage>1844</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20001015)89:8&lt;1835::AID-CNCR26&gt;3.0.CO;2-H</pub-id>
          <pub-id pub-id-type="pmid">11042581</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schmook</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Stockfleth</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lischner</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gahn</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Christophers</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hauschild</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP)</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2003</year>
          <volume>28</volume>
          <fpage>31</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2230.2003.01132.x</pub-id>
          <pub-id pub-id-type="pmid">12558625</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Paul</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Radny</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kr&#xF6;ber</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Paul</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blaheta</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Garbe</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Intralesional rituximab for cutaneous B-cell lymphoma</article-title>
          <source>Br J Dermatol</source>
          <year>2001</year>
          <volume>144</volume>
          <fpage>1239</fpage>
          <lpage>1243</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2133.2001.04241.x</pub-id>
          <pub-id pub-id-type="pmid">11422050</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Heinzerling</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dummer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kempf</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Schmid</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Burg</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma</article-title>
          <source>Arch Dermatol</source>
          <year>2000</year>
          <volume>136</volume>
          <fpage>374</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="doi">10.1001/archderm.136.3.374</pub-id>
          <pub-id pub-id-type="pmid">10724200</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kennedy</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Blum</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McCormack</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Prince</surname>
            <given-names>HM</given-names>
          </name>
          <article-title>Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases</article-title>
          <source>Australas J Dermatol</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>34</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-0960.2004.00027.x</pub-id>
          <pub-id pub-id-type="pmid">14961906</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fink-Puches</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>IH</given-names>
          </name>
          <name>
            <surname>Zalaudek</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kerl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cerroni</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Treatment of primary cutaneous B-cell lymphoma with rituximab</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>847</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2005.01.093</pub-id>
          <pub-id pub-id-type="pmid">15858476</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fierro</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Savoia</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Quaglino</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Novelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Barberis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bernengo</surname>
            <given-names>MG</given-names>
          </name>
          <article-title>Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2003</year>
          <volume>49</volume>
          <fpage>281</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1067/S0190-9622(03)00855-7</pub-id>
          <pub-id pub-id-type="pmid">12894078</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Grange</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Petrella</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Beylot-Barry</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>D&#x2019;Incan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Delaunay</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Machet</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Avril</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Dalac</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bernard</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Carlotti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Esteve</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vergier</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dechelotte</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cassagnau</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Courville</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Saiag</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Laroche</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bagot</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wechsler</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>3662</fpage>
          <lpage>3668</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2003-08-2726</pub-id>
          <pub-id pub-id-type="pmid">14726400</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bekkenk</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Postma</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Meijer</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Willemze</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Frequency of central nervous system involvement in primary cutaneous B-cell lymphoma</article-title>
          <source>Cancer</source>
          <year>2000</year>
          <volume>89</volume>
          <fpage>913</fpage>
          <lpage>919</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20000815)89:4&lt;913::AID-CNCR26&gt;3.0.CO;2-8</pub-id>
          <pub-id pub-id-type="pmid">10951357</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
